Toralizumab
id:
toralizumab-298-13235158
title:
Toralizumab
text:
Toralizumab was a humanized monoclonal antibody and an immunosuppressive drug. Possible indications included treatment of antibody-mediated disorders, T-cell-mediated diseases, and B-cell malignancies such as CLL/small lymphocytic lymphoma, follicular cell lymphoma grade I or II, marginal zone lymphoma, mantle cell lymphoma, MALT lymphoma, Waldenström's macroglobulinemia, monocytoid B-cell lymphoma; relapsed/refractory Hodgkin's disease). In Phase II clinical trials regarding multiple sclerosis
brand slug:
wiki
category slug:
encyclopedia
description:
Monoclonal antibody
original url:
https://en.wikipedia.org/wiki/Toralizumab
date created:
date modified:
2023-05-14T00:48:38Z
main entity:
{"identifier":"Q7825392","url":"https://www.wikidata.org/entity/Q7825392"}
image:
fields total:
13
integrity:
14